D-0784-2021 Class III Terminated

Recalled by Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

FDA drug recall D-0784-2021 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Aug 20, 2021 and is designated Class III. Reason for recall: Subpotent The recall status is terminated (terminated Apr 5, 2022). Affected quantity: 14,544 bottles.

Recall details

Product Type
Drugs
Report Date
Sep 8, 2021
Initiation Date
Aug 20, 2021
Termination Date
Apr 5, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14,544 bottles

Product description

Donepezil HCL Tablets, USP, 5 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801 NDC 59746-329-90

Reason for recall

Subpotent

Distribution pattern

Product was distributed nationwide.

Code information

Lot # DN120006A, exp. date 12/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0784-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0784-2021. Report a data issue: hello@regdatalab.com.